TATDN2 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-58326
Key Product Details
Species Reactivity
Human
Applications
Immunocytochemistry/ Immunofluorescence
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was developed against a recombinant protein corresponding to the following amino acid sequence: GKVKHNWSSTSEGCPRKRSCLREPCDVAPSSRPAQRSASRSGGPSSPKRLKAQKEDDVACSRRLSWGSSRRRNNSSSS
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for TATDN2 Antibody
Immunocytochemistry/ Immunofluorescence: TATDN2 Antibody [NBP2-58326]
Immunocytochemistry/Immunofluorescence: TATDN2 Antibody [NBP2-58326] - Staining of human cell line U-2 OS shows localization to nucleoplasm & cytosol.Applications for TATDN2 Antibody
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
0.25-2 ug/ml
Application Notes
Immunocytochemistry/Immunofluorescence Fixation Permeabilization: Use PFA/Triton X-100.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS (pH 7.2) and 40% Glycerol
Preservative
0.02% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: TATDN2
Alternate Names
KIAA0218, MGC126819, MGC126825, putative deoxyribonuclease TATDN2, TatD DNase domain containing 2
Gene Symbol
TATDN2
Additional TATDN2 Products
Product Documents for TATDN2 Antibody
Product Specific Notices for TATDN2 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...